Literature DB >> 19460548

Alcohol abuse and de novo tumors in liver transplantation.

G Zanus1, A Carraro, A Vitale, E Gringeri, F D'Amico, M Valmasoni, F E D'Amico, A Brolese, P Boccagni, D Neri, N Srsen, P Burra, P Feltracco, P Bonsignore, M Scopelliti, U Cillo.   

Abstract

INTRODUCTION: Organ transplant recipients show an increased incidence of cancer ranging from 4% to 16% owing to several causes: immunosuppression, viral infection, individual predisposition, and so on.
MATERIALS AND METHODS: We retrospectively reviewed the records of 43/683 (6.3%) recipients of 734 liver transplants performed from November 1991 to November 2008 who experienced a de novo neoplasm.
CONCLUSION: Alcohol abuse significantly increased the rate of all de novo neoplasms and particularly pharyngogastroesophageal cancers among population of liver transplant recipients. Minimization of immunosuppressive therapy is necessary to reduce the risk of a de novo neoplasm. Strict posttransplant follow-up is required to identify early gastroenteric tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19460548     DOI: 10.1016/j.transproceed.2009.03.055

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

Review 1.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  De novo malignancy post-liver transplantation: a single center, population controlled study.

Authors:  Hemant Chatrath; Kenneth Berman; Raj Vuppalanchi; James Slaven; Paul Kwo; A Joseph Tector; Naga Chalasani; Marwan Ghabril
Journal:  Clin Transplant       Date:  2013-06-30       Impact factor: 2.863

Review 3.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

Authors:  Carlos Jiménez-Romero; Iago Justo-Alonso; Félix Cambra-Molero; Jorge Calvo-Pulido; Álvaro García-Sesma; Manuel Abradelo-Usera; Oscar Caso-Maestro; Alejandro Manrique-Municio
Journal:  World J Hepatol       Date:  2015-05-08

5.  De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.

Authors:  Anisha Tiwari; Sanjiv Saigal; Narendra S Choudhary; Sujeet Saha; Amit Rastogi; Prashant Bhangui; Neeraj Saraf; Thiagrajan Srinivasan; Sanjay K Yadav; Dheeraj Gautam; Samiran Nundy; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-02-13

Review 6.  Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

Authors:  Pavan Kedar Mukthinuthalapati; Raghavender Gotur; Marwan Ghabril
Journal:  World J Hepatol       Date:  2016-04-28

7.  KASL clinical practice guidelines: management of alcoholic liver disease.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2013-09-30

8.  Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.

Authors:  Hua Xiao; Jianmin Bian; Lei Zhang; Zhaoming Wang; Aixing Ding
Journal:  Oncol Lett       Date:  2014-10-09       Impact factor: 2.967

9.  Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review.

Authors:  Kun Yang; Hong Zhu; Chong-Cheng Chen; Tian-Fu Wen; Wei-Han Zhang; Kai Liu; Xin-Zu Chen; Dong-Jiao Guo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.